Literature DB >> 25260402

Characterization of cardiac oxidative stress levels in patients with atrial fibrillation.

Ayako Okada1, Yuichiro Kashima2, Takeshi Tomita1, Takahiro Takeuchi1, Kazunori Aizawa1, Masafumi Takahashi3, Uichi Ikeda1.   

Abstract

Atrial fibrillation (AF) is associated with oxidative stress and elevated brain natriuretic peptide (BNP) levels. However, the exact cardiac origin of oxidative stress and its association with BNP levels in AF patients remain unclear. Therefore, we investigated the chamber-specific plasma oxidative stress levels in patients with paroxysmal AF (PAF) and persistent AF (PSAF). Diacron-reactive oxygen metabolite (dROM) levels were measured in patients with PAF (n = 50) and PSAF (n = 35) at different cardiac sites before ablation and in peripheral vein 3 months after ablation. For all sites, dROM levels were higher in PSAF patients than in PAF patients; the levels were the highest in the coronary sinus at 429.0 (interquartile range: 392.0-449.0) vs. 374.0 (357.0-397.8) Carratelli units (P < 0.05). dROM levels in the coronary sinus were related to the BNP levels (r = 0.436, P < 0.001). Furthermore, the reduction in the peripheral dROM levels was related to that in the peripheral BNP levels in patients with symptomatic improvement (r = 0.473, P < 0.001). Cardiac oxidative stress may either be a cause or consequence of prolonged AF, and cardiac oxidative stress levels correlated with BNP levels, though a possible source of oxidative stress in AF patients may be systemic circulation.

Entities:  

Keywords:  Ablation; Atrial fibrillation; Brain natriuretic peptide; Oxidative stress

Mesh:

Substances:

Year:  2014        PMID: 25260402     DOI: 10.1007/s00380-014-0582-8

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  24 in total

1.  Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation.

Authors:  M J Mihm; F Yu; C A Carnes; P J Reiser; P M McCarthy; D R Van Wagoner; J A Bauer
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

Review 2.  New ideas about atrial fibrillation 50 years on.

Authors:  Stanley Nattel
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

3.  Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation.

Authors:  Masayuki Shimano; Rei Shibata; Yasuya Inden; Naoki Yoshida; Tomohiro Uchikawa; Yukiomi Tsuji; Toyoaki Murohara
Journal:  Heart Rhythm       Date:  2009-03-11       Impact factor: 6.343

Review 4.  Atrial fibrillation pathophysiology: implications for management.

Authors:  Yu-ki Iwasaki; Kunihiro Nishida; Takeshi Kato; Stanley Nattel
Journal:  Circulation       Date:  2011-11-15       Impact factor: 29.690

5.  Assessment of factors affecting plasma BNP levels in patients with chronic atrial fibrillation and preserved left ventricular systolic function.

Authors:  Byung Jin Kim; Sang Jun Hwang; Ki Chul Sung; Bum Soo Kim; Jin Ho Kang; Man Ho Lee; Jung Ro Park
Journal:  Int J Cardiol       Date:  2006-09-07       Impact factor: 4.164

6.  Characterization of cardiac brain natriuretic peptide release in patients with paroxysmal atrial fibrillation undergoing left atrial ablation.

Authors:  Paul A Gould; L J Gula; V Bhayana; R N Subbiah; C Bentley; Raymond Yee; George J Klein; Andrew D Krahn; Allan C Skanes
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12-04

7.  Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial-tachycardia remodeling in dogs.

Authors:  Akiko Shiroshita-Takeshita; Gernot Schram; Joel Lavoie; Stanley Nattel
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

Review 8.  Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data.

Authors:  Tim T Issac; Hisham Dokainish; Nasser M Lakkis
Journal:  J Am Coll Cardiol       Date:  2007-11-05       Impact factor: 24.094

9.  Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery.

Authors:  Young M Kim; Hassan Kattach; Chandi Ratnatunga; Ravi Pillai; Keith M Channon; Barbara Casadei
Journal:  J Am Coll Cardiol       Date:  2008-01-01       Impact factor: 24.094

10.  Pentraxin 3 is a local inflammatory marker in atrial fibrillation.

Authors:  Takeshi Soeki; Sachiko Bando; Etsuko Uematsu; Tomomi Matsuura; Toshiyuki Niki; Takayuki Ise; Kenya Kusunose; Junko Hotchi; Yuka Ueda; Noriko Tomita; Koji Yamaguchi; Shusuke Yagi; Daiju Fukuda; Yoshio Taketani; Takashi Iwase; Hirotsugu Yamada; Tetsuzo Wakatsuki; Michio Shimabukuro; Masataka Sata
Journal:  Heart Vessels       Date:  2013-08-27       Impact factor: 2.037

View more
  8 in total

1.  Cardiac hyaluronan may be associated with the persistence of atrial fibrillation.

Authors:  Ayako Okada; Yuichiro Kashima; Takeshi Tomita; Takahiro Takeuchi; Yasutaka Oguchi; Koji Yoshie; Wataru Shoin; Morio Shoda; Kenichi Nitta; Koichiro Kuwahara; Hiroshi Imamura
Journal:  Heart Vessels       Date:  2017-04-04       Impact factor: 2.037

2.  Selective downregulation of mitochondrial electron transport chain activity and increased oxidative stress in human atrial fibrillation.

Authors:  Larisa Emelyanova; Zain Ashary; Milanka Cosic; Ulugbek Negmadjanov; Gracious Ross; Farhan Rizvi; Susan Olet; David Kress; Jasbir Sra; A Jamil Tajik; Ekhson L Holmuhamedov; Yang Shi; Arshad Jahangir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

3.  Short- and long-term inhibition of cardiac inward-rectifier potassium channel current by an antiarrhythmic drug bepridil.

Authors:  Fangfang Ma; Hiroki Takanari; Kimiko Masuda; Masaki Morishima; Katsushige Ono
Journal:  Heart Vessels       Date:  2015-10-26       Impact factor: 2.037

4.  Relationship between HRV measurements and demographic and clinical variables in a population of patients with atrial fibrillation.

Authors:  Carmelo Buttà; Antonino Tuttolomondo; Alessandra Casuccio; Rossella Petrantoni; Giuseppe Miceli; Francesco Cuttitta; Antonio Pinto
Journal:  Heart Vessels       Date:  2016-03-03       Impact factor: 2.037

5.  Efficacy of Intravenous Administration of Landiolol in Patients With Acute Heart Failure and Supraventricular Tachyarrhythmia.

Authors:  Shunsuke Kiuchi; Hiroto Aikawa; Shinji Hisatake; Takayuki Kabuki; Takashi Oka; Shintaro Dobashi; Takahiro Fujii; Takanori Ikeda
Journal:  J Clin Med Res       Date:  2017-04-01

6.  Ibutilide protects against cardiomyocytes injury via inhibiting endoplasmic reticulum and mitochondrial stress pathways.

Authors:  Yu Wang; Yi-Li Wang; Xia Huang; Yang Yang; Ya-Jun Zhao; Cheng-Xi Wei; Ming Zhao
Journal:  Heart Vessels       Date:  2016-09-17       Impact factor: 2.037

7.  Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study).

Authors:  Darae Ko; Eric M Riles; Ernaldo G Marcos; Jared W Magnani; Steven A Lubitz; Honghuang Lin; Michelle T Long; Renate B Schnabel; David D McManus; Patrick T Ellinor; S Vasan Ramachandran; Thomas J Wang; Robert E Gerszten; Emelia J Benjamin; Xiaoyan Yin; Michiel Rienstra
Journal:  Am J Cardiol       Date:  2016-08-24       Impact factor: 2.778

8.  Lipidomic profiling reveals free fatty acid alterations in plasma from patients with atrial fibrillation.

Authors:  Youngae Jung; Youngjin Cho; Nami Kim; Il-Young Oh; Sang Won Kang; Eue-Keun Choi; Geum-Sook Hwang
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.